Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6139406 | Virology | 2015 | 7 Pages |
Abstract
These findings support the impact of EcPV2 in equine gSCC development and recommend EcPV2 L1 VLP as prophylactic vaccine against EcPV2 infection and associated disease in equids.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Virology
Authors
Christina Schellenbacher, Saeed Shafti-Keramat, Bettina Huber, Dieter Fink, Sabine Brandt, Reinhard Kirnbauer,